Model
Edge
Recursion Pharmaceuticals, Inc.
RXRX
Filing type
4
Filing date
Oct 6, 2026
Updated
Oct 7, 2026 ยท 4:08 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership